Global Summit on Cancer Advances
(GSCA 2027)
Advancing Precision Oncology, Translational Science, and Next-Generation Immunotherapy in San Francisco, California.
GSCA Faculty Credit Policy
Because academic institutions operate on multi-year grant cycles, 100% of registration fees from the GSCA 2026 Virtual Summit convert directly into a credit voucher toward attending the 2027 in-person conference in San Francisco.
About the 2027 In-Person Congress
The Global Summit on Cancer Advances (GSCA 2027) will convene leading oncology investigators, clinical practitioners, translational scientists, and industry pioneers for two days of rigorous scientific exchange in San Francisco.
Anchored at the Hyatt Regency San Francisco Downtown SOMA, GSCA 2027 provides an intimate and collaborative face-to-face forum for debating breakthroughs in cancer biology, evaluating clinical trial outcomes, and forming multi-institutional research partnerships.
GSCA 2027 Key Deadlines
Plan your institutional travel approvals, grant submissions, and scientific abstract delivery.
Early-Bird Registration
March 30, 2027
Discounted delegate & student rates
Abstract Submission
June 15, 2027
Oral & e-poster submissions close
Speaker Confirmation
July 31, 2027
Final plenary program announcement
In-Person Congress
October 14–15, 2027
San Francisco, California
Core Scientific Tracks (San Francisco 2027)
Covering basic science discovery to clinical translational implementation.
Cancer Biology, Genomics & Epigenetics
Chromatin dynamics, non-coding drivers, oncogenic signaling cascades, and tumor evolutionary kinetics.
Immuno-Oncology & Cellular Therapies
Next-gen CAR-T/NK cell platforms, bispecific T-cell engagers, neoantigen cancer vaccines, and checkpoint resistance.
Liquid Biopsy & Multi-Omic Biomarkers
Circulating tumor DNA (ctDNA) dynamics, extracellular vesicles, early detection panels, and minimal residual disease (MRD).
Antibody-Drug Conjugates & Targeted Delivery
Novel ADC payload chemistries, linker innovations, targeted radiopharmaceuticals, and blood-brain barrier penetration.
AI, Digital Pathology & Trial Stratification
Deep learning in clinical histopathology, spatial transcriptomics analysis, and computational biomarker discovery.
Clinical Oncology & Survivorship Care
Multidisciplinary patient management, de-escalation clinical trials, supportive oncology, and global health disparities.
Hyatt Regency San Francisco Downtown SOMA
Situated in San Francisco’s dynamic South of Market (SOMA) arts and innovation district, the Hyatt Regency SOMA provides premier meeting facilities, cutting-edge presentation technology, and convenient proximity to the Moscone Center and biotechnology corridors.
- Address: 50 3rd St, San Francisco, CA 94103, USA
- Accessibility: Direct access via SFO International Airport, OAK, & BART transit lines.
- Accommodation: Special contracted delegate room blocks available for registered attendees.
Join the GSCA 2027 Faculty in San Francisco
Speaker slots and provisional abstract reviews are now being coordinated. Express your interest early to guarantee placement in our preliminary program booklet.
Have questions regarding 2026/2027 rollover credits, sponsorships, or keynotes?
Contact Program Manager Ria D'Costa at info@gsca.researchriser.org